Healthcare Trust, Inc. HLTC

expiry = 2018-04-12...l (the “Instructions”). This Offer to Purchase, the Letter of Transmittal and the Instructions, constitute the “Offer.” Unless extended or withdrawn, the Offer, proration period and withdrawal rights will expire at 11:59 p.m. Eastern Time, on April 12, 2018 (the “Expiration Date”). You may tender all, a portion or none of your Shares. Stockholders desiring to tender all or any portion of their Shares for purchase must complete and sign a Letter of Transmittal and deliver it to the Company in...

expiry = 2018-04-30...ffer, from 2,000,000 Shares to 230,000 Shares, reducing the maximum amount we would be required to pay to purchase Shares in the Offer to approximately $3.0 million. The Expiration Date for the Offer has been extended from 11:59 p.m., Eastern Time, on April 12, 2018, to 11:59 p.m., Eastern Time, on April 30, 2018 in order to provide stockholders additional time to evaluate the Offer. If you have not previously tendered Shares and you wish to tender all or any portion of your Shares, you should follow the instructions described in Section 2 of the O...

mechanism = FIXED...(A)(1)(A) tv488280-sctoi_DIV_01-exa1a - none - 1.645571s ​ Exhibit (a)(1)(A)​ OFFER TO PURCHASE HEALTHCARE TRUST, INC. 405 PARK AVENUE, 4 TH FLOOR NEW YORK, NY 10022 (212) 415-6500 OFFER TO PURCHASE UP TO 2,000,000 SHARES OF ITS OUTSTANDING COMMON STOCK AT A PURCHASE PRICE OF $13.15 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M. EASTERN TIME, APRIL 12, 2018, UNLESS EXTENDED OR WITHDRAWN Dear Stockholder: Healthcare Trust, Inc. (the “Company,” “we,” “us,” or “our”) is offering to purchase up to 2,000,000 shares of the Company’s common stock, par value $0.01 per share (“Shares”), for cash...

mechanism = FIXED...RCHASE TO 230,000 SHARES AND EXTEND THE EXPIRATION OF THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS UNTIL 11:59 P.M. EASTERN TIME, APRIL 30, 2018, UNLESS EXTENDED OR WITHDRAWN For OFFER TO PURCHASE UP TO 230,000 SHARES OF ITS OUTSTANDING COMMON STOCK AT A PURCHASE PRICE OF $13.15 PER SHARE Dear Stockholder: Healthcare Trust, Inc. (the “Company,” “we,” “us,” or “our”) filed an offer to purchase (the “Original Offer to Purchase”) and a related letter of transmittal as exhibits to a Tender Offer Statement on Schedule TO filed with the Securities and Exchange Commission (the “SEC”) on March 13, 2018. These materials related to...

must_tender_all = True...es under the SRP, and paying operating and administrative expenses or continuing debt service obligations. ​ • Purchases of Shares pursuant to the Offer will increase the proportionate interest of stockholders that do not tender their Shares. ​ • Stockholders who tender all of their Shares will give up the opportunity to participate in any potential future benefits from owning Shares, including the right to receive any future distributions that we may pay and any future increases in the value of the Shares. ​ Our purchases of Shares pursuant to the Offer will not result in the deregistration of our Shares under the Securit...

price = USD 13.15...FFER TO PURCHASE HEALTHCARE TRUST, INC. 405 PARK AVENUE, 4 TH FLOOR NEW YORK, NY 10022 (212) 415-6500 OFFER TO PURCHASE UP TO 2,000,000 SHARES OF ITS OUTSTANDING COMMON STOCK AT A PURCHASE PRICE OF $13.15 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M. EASTERN TIME, APRIL 12, 2018, UNLESS EXTENDED OR WITHDRAWN Dear Stockholder: Healthcare Trust, Inc. (the “Company,” “we,” “us,” or “our”) is of...

price = USD 13.15...D AND WITHDRAWAL RIGHTS UNTIL 11:59 P.M. EASTERN TIME, APRIL 30, 2018, UNLESS EXTENDED OR WITHDRAWN For OFFER TO PURCHASE UP TO 230,000 SHARES OF ITS OUTSTANDING COMMON STOCK AT A PURCHASE PRICE OF $13.15 PER SHARE Dear Stockholder: Healthcare Trust, Inc. (the “Company,” “we,” “us,” or “our”) filed an offer to purchase (the “Original Offer to Purchase”) and a related letter of transmittal as exhibits to a Tender Offer Statement on...

priority = True...e Offer by up to, but not more than, 2% of the outstanding Shares without amending or extending the Offer. Properly tendering Shares assures you that at least a portion of your Shares will be purchased so long as we purchase Shares under the Offer (subject to provisions relating to “odd lot” priority and proration described in “The Offer — Section 1”). We will announce the preliminary results of the Offer through an amendment to the Schedule TO, including the expected proration factor, and pay the Purchase Price in cash, less any applicable withholding taxes and without interest, for the Shares we accept for payment promptly after th...

threshold = 100...chase and, therefore, may be relevant to a stockholder’s decision whether to tender Shares. Each stockholder should consult with their tax advisor to evaluate the tax consequences of tendering or selling Shares in the Offer. See “The Offer — Section 16.” If I own fewer than 100 Shares and I tender all of my Shares, will I be subject to proration? If you own beneficially or of record fewer than 100 Shares in the aggregate, you will not be subject to proration if: (1) you properly tender all of these Shares, (2) you do not properly withdraw them before the Expiration Date, and (3) you complete the Letter of Transmittal...

txn_type = TENDER_OFFEREX-99.(A)(1)(A) 2 tv488280-exa1a.htm EXHIBIT (A)(1)(A) tv488280-sctoi_DIV_01-exa1a - none - 1.645571s ​ Exhibit (a)(1)(A)​ OFFER TO PURCHASE HEALTHCARE TRUST, INC. 405 PARK AVENUE, 4 TH FLOOR NEW YORK, NY 10022 (212) 415-6500 OFFER TO PURCHASE UP TO 2,000,000 SHARES OF ITS OUTSTANDING COMMON STOCK AT A PURCHASE PRICE OF $13.15 PER SHARE THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 11:59 P.M. EASTERN TIME, APRIL 12, 2018, UNLESS EXTENDED OR WITHDRAWN Dear S...

txn_type = TENDER_OFFEREX-99.(A)(1)(E) 3 tv490222_exa1e.htm EXHIBIT (A)(1)(E) Exhibit (a)(1)(E) AMENDMENT AND SUPPLEMENT NO. 1 TO OFFER TO PURCHASE By HEALTHCARE TRUST, INC. 405 PARK AVENUE, 4TH FLOOR NEW YORK, NY 10022 (212) 415-6500 TO DECREASE THE NUMBER OF SHARES THE COMPANY IS OFFERING TO PURCHASE TO 230,000 SHARES AND EXTEND THE EXPIRATION OF THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS UNTIL 11:59 P.M. EASTERN TIME, APRIL 30, 2018, UNLESS EXTENDED OR WITHDRAWN For OFFER...

txn_type = TENDER_OFFER...ecurities and Exchange Commission, at a purchase price equal to $13.15 per Share, net to the seller in cash, less any applicable withholding taxes and without interest. The Company’s offer was made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated March 13, 2018 (the “Original Offer to Purchase”), as amended and supplemented by Amendment and Supplement No. 1 thereto, dated April 3, 2018 (“Supplement No. 1” and, together with the Original Offer to Purchase, as the same has been and may be further amended or supplemented from time to time, the “Offer to Purchase”), and in the...

untradeable = True...ssets and liabilities in connection with the calculation of Estimated Per-Share NAV, see the Company’s Current Report on Form 8-K dated April 5, 2017 filed with the SEC. As noted therein, because the Shares are not listed on a national securities exchange and there is no established trading market for the Shares, Estimated Per-Share NAV does not represent the: (i) the price at which Shares would trade at on a national securities exchange or a third party would pay for the Company, (ii) the amount a stockholder would obtain if he or she tried to sell his or her Shares or (iii) the amount stockholders would receive if the Company liquidated its as...

untradeable = True...ssets and liabilities in connection with the calculation of Estimated Per-Share NAV, see the Company’s Current Report on Form 8-K dated April 3, 2018 filed with the SEC. As noted therein, because the Shares are not listed on a national securities exchange and there is no established trading market for the Shares, Estimated Per-Share NAV does not represent the: (i) the price at which Shares would trade at on a national securities exchange or a third party would pay for the Company, (ii) the amount a stockholder would obtain if he or she tried to sell his or her Shares or (iii) the amount stockholders would receive if the Company liquidated its as...

accepted = 229999...93,426 Shares were validly tendered and not validly withdrawn, except for tenders of odd lots, and, therefore, the Offer was oversubscribed. In accordance with the terms of the Offer, the Company has accepted for purchase 229,999 Shares at a purchase price equal to $13.15 per Share, net to the seller in cash, less any applicable withholding taxes and without interest, for a total cost of approximately $3.0 million, excluding fees and expenses relating to the Offer. The Company is not purchasing the full 230,000...

expired_on = 2018-05-01...nt No. 3. Item 11. Additional Information. Item 11 of the Schedule TO is hereby amended and supplemented by adding the following information thereto: “The Offer proration period and withdrawal rights expired at 11:59 p.m. Eastern Time, on May 1, 2018, and the Offer was not extended. The Company has been advised by the Depositary that a total 793,426 Shares were validly tendered and not validly withdrawn, except for tenders of odd lots, and, therefore, the Offer was oversubscribed. In accordance with the terms of the Offer, t...

oddlot_filled = YES...and odd lots. Payment for the Shares purchased pursuant to the Offer will commence promptly. The Company has determined that the proration factor for the Offer, after giving effect to the priority of odd lots, which were accepted in full, is approximately 40.8% of the total number of Shares properly tendered and not properly withdrawn by all stockholders, except for tenders of odd lots. The Shares accepted for purchase in the Offer represent 0.25% of the issued and outstanding Shares as of February 28, 2018.” SI...

tendered = 793426...reto: “The Offer proration period and withdrawal rights expired at 11:59 p.m. Eastern Time, on May 1, 2018, and the Offer was not extended. The Company has been advised by the Depositary that a total 793,426 Shares were validly tendered and not validly withdrawn, except for tenders of odd lots, and, therefore, the Offer was oversubscribed. In accordance with the terms of the Offer, the Company has accepted for purchase 229,999 Shares at a purchase price equal to $13.15 per Share, net to the seller in cash, less...